Popular Education
2023 Revision to USP 797: What Home Infusion Pharmacies Need to Know
On Novemeber 1, 2022 USP released the revised version of General Chapter Pharmaceutical Compounding--Sterile Preparations, which becomes enforceable November 1, 2023.
Treatment of Neurological Disorders with Immunoglobulin Therapy
This program will review the current immunglobulin therapies that are FDA approved for both autoimmune and neurological disorders. 1 CE
Talk Infusion: Mid-2024 Regulatory and Legislative Updates
Catch up with the latest billing policy updates as well as regulatory and legislative action affecting home and alternate site infusion providers.
